These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36690934)

  • 1. Major risk factors for Streptococcus dysgalactiae subsp. equisimilis bacteremia: a population-based study.
    Nevanlinna V; Huttunen R; Aittoniemi J; Luukkaala T; Rantala S
    BMC Infect Dis; 2023 Jan; 23(1):43. PubMed ID: 36690934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two cases of cardiac device-related endocarditis due to Streptococcus dysgalactiae subsp. equisimilis (group C or G streptococci).
    Rantala S; Tuohinen S
    BMC Infect Dis; 2014 Mar; 14():174. PubMed ID: 24678588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Streptococcus dysgalactiae subsp. equisimilis bacteremia: an emerging infection.
    Rantala S
    Eur J Clin Microbiol Infect Dis; 2014 Aug; 33(8):1303-10. PubMed ID: 24682845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, seasonal pattern, and clinical manifestations of Streptococcus dysgalactiae subspecies equisimilis bacteremia; a population-based study.
    Nevanlinna V; Huttunen R; Aittoniemi J; Luukkaala T; Rantala S
    Eur J Clin Microbiol Infect Dis; 2023 Jul; 42(7):819-825. PubMed ID: 37119347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-familial transmission of Streptococcus dysgalactiae subsp. equisimilis (SDSE): A first case report and review of the literature.
    Sunagawa K; Shirafuji T; Sun G; Arai R; Azuma H; Miyoshi-Akiyama T; Katano H
    J Infect Chemother; 2022 Jun; 28(6):819-822. PubMed ID: 35115237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic relationships deduced from emm and multilocus sequence typing of invasive Streptococcus dysgalactiae subsp. equisimilis and S. canis recovered from isolates collected in the United States.
    Ahmad Y; Gertz RE; Li Z; Sakota V; Broyles LN; Van Beneden C; Facklam R; Shewmaker PL; Reingold A; Farley MM; Beall BW
    J Clin Microbiol; 2009 Jul; 47(7):2046-54. PubMed ID: 19386831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Streptococcus dysgalactiae subsp. equisimilis and S. equi subsp. zooepidemicus in a sample of healthy dogs, cats and horses.
    Acke E; Midwinter AC; Lawrence K; Gordon SJ; Moore S; Rasiah I; Steward K; French N; Waller A
    N Z Vet J; 2015 Sep; 63(5):265-71. PubMed ID: 25695401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of virulence genes to clinical manifestations and outcome in patients with Streptococcus dysgalactiae subspecies equisimilis bacteremia.
    Tsai CT; Chi CY; Ho CM; Lin PC; Chou CH; Wang JH; Wang JH; Lin HC; Tien N; Lin KH; Ho MW; Lu JJ
    J Microbiol Immunol Infect; 2014 Dec; 47(6):462-8. PubMed ID: 24210866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the Genomics and Mouse Virulence of an Emergent Clone of Streptococcus dysgalactiae Subspecies
    Beres SB; Olsen RJ; Long SW; Eraso JM; Boukthir S; Faili A; Kayal S; Musser JM
    Microbiol Spectr; 2023 Mar; 11(2):e0455022. PubMed ID: 36971562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of a viridans group strain reveals a case of bacteremia due to lancefield group G alpha-hemolytic Streptococcus dysgalactiae subsp equisimilis in a patient with pyomyositis and reactive arthritis.
    Woo PC; Teng JL; Lau SK; Lum PN; Leung KW; Wong KL; Li KW; Lam KC; Yuen KY
    J Clin Microbiol; 2003 Feb; 41(2):613-8. PubMed ID: 12574255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Streptococcal toxic-shock syndrome due to Streptococcus dysgalactiae subspecies equisimilis in breast cancer-related lymphedema: a case report.
    Sumazaki M; Saito F; Ogata H; Yoshida M; Kubota Y; Magoshi S; Kaneko H
    J Med Case Rep; 2017 Jul; 11(1):191. PubMed ID: 28705211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of mitogenic activity of speG- and speG(dys)-positive Streptococcus dysgalactiae subspecies equisimilis isolates from patients with invasive infections.
    Brandt CM; Schweizer KG; Holland R; Lütticken R; Freyaldenhoven BS
    Int J Med Microbiol; 2005 Dec; 295(8):539-46. PubMed ID: 16325550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Streptococcus dysgalactiae subsp. equisimilis Bacteremia, Finland, 1995-2004.
    Rantala S; Vahakuopus S; Vuopio-Varkila J; Vuento R; Syrjanen J
    Emerg Infect Dis; 2010 May; 16(5):843-6. PubMed ID: 20409380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Streptococcus dysgalactiae subsp. equisimilis possessing Lancefield's group A antigen].
    Katsukawa C; Tamaru A; Morikawa Y
    Kansenshogaku Zasshi; 2002 Mar; 76(3):155-60. PubMed ID: 11974882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seropositivity for Antibodies to DRS-G, a Virulence Factor from Streptococcus dysgalactiae subsp. equisimilis, Is an Independent Risk Factor for Poststreptococcus Glomerulonephritis and Chronic Kidney Disease in Mumbai, India.
    Hule GP; Karmarkar MG; Cameron A; Hase N; Khopkar U; Mehta PR; McNeilly CL; McMillan D; Sriprakash KS
    Clin Vaccine Immunol; 2015 Aug; 22(8):938-42. PubMed ID: 26084513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. rDNA sequence analyses of Streptococcus dysgalactiae subsp. equisimilis isolates from pigs.
    Kawata K; Minakami T; Mori Y; Katsumi M; Kataoka Y; Ezawa A; Kikuchi N; Takahashi T
    Int J Syst Evol Microbiol; 2003 Nov; 53(Pt 6):1941-6. PubMed ID: 14657127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal Expansion of Multidrug-Resistant Streptococcus dysgalactiae Subspecies equisimilis Causing Bacteremia, Japan, 2005-2021.
    Shinohara K; Murase K; Tsuchido Y; Noguchi T; Yukawa S; Yamamoto M; Matsumura Y; Nakagawa I; Nagao M
    Emerg Infect Dis; 2023 Mar; 29(3):528-539. PubMed ID: 36823027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergent Invasive Group A Streptococcus dysgalactiae subsp. equisimilis, United States, 2015-2018.
    Chochua S; Rivers J; Mathis S; Li Z; Velusamy S; McGee L; Van Beneden C; Li Y; Metcalf BJ; Beall B
    Emerg Infect Dis; 2019 Aug; 25(8):1543-1547. PubMed ID: 31158071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of invasive Streptococcus dysgalactiae subsp. equisimilis. Multicenter study: Argentina 2011-2012.
    Traverso F; Blanco A; Villalón P; Beratz N; Sáez Nieto JA; Lopardo H;
    Rev Argent Microbiol; 2016; 48(4):279-289. PubMed ID: 28341023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence, clinical characteristics, and outcomes of Streptococcus dysgalactiae subspecies equisimilis bacteremia in a tertiary hospital: comparison with S. agalactiae bacteremia.
    Park JH; Jung J; Kim MJ; Sung H; Kim MN; Chong YP; Kim SH; Lee SO; Kim YS; Woo JH; Choi SH
    Eur J Clin Microbiol Infect Dis; 2019 Dec; 38(12):2253-2258. PubMed ID: 31392445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.